Where others have failed will Atl1102 succeed ?, page-457

Pfizer is fighting back against a report that it hid the potential of a blockbuster drug to prevent Alzheimer’s disease in order to avoid shelling out for a “costly clinical trial.”Researchers at Pfizer in 2015 found that Enbrel, an anti-inflammatory drug used to treat rheumatoid arthritis, seemed to reduce the risk of Alzheimer’s disease by 64 percent,
the Washington Post reported Tuesday.

People we’re on a winner $$$
Pifzer know that an anti inflammatory drug will treat Alzheimer’s
and also we know it will treat Rheumatoid Arthritis as well
2 very very large populations…

So Meph I think your correct. $$$$$